Page last updated: 2024-11-05

ethyl oenanthate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethyl oenanthate, also known as ethyl heptanoate, is a colorless liquid ester with a fruity, wine-like aroma. It is naturally found in various fruits, wines, and cheeses. It is synthesized through the reaction of heptanoic acid with ethanol in the presence of a catalyst. Ethyl oenanthate is used as a flavoring agent in food and beverages, particularly in artificial fruit flavors, and is also used in perfumes. It is also employed as a solvent in some chemical processes. Studies on ethyl oenanthate focus on its sensory properties, its role in food chemistry, and its potential applications in various industries.'

ethyl heptanoate : The fatty acid ethyl ester of heptanoic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7797
CHEMBL ID3184220
CHEBI ID86618
SCHEMBL ID1585
MeSH IDM0100619

Synonyms (65)

Synonym
fema no. 2437
ai3-24251
ethyl heptanoate (natural)
einecs 203-382-9
ccris 1344
brn 1752311
nsc 8891
ethyl enantate
ethyl oenanthylate
oenanthic ether
ethyl heptanoate
nsc8891
oleum vitis viniferae
106-30-9
ethyl heptoate
heptanoic acid, ethyl ester
ethyl n-heptanoate
enanthylic ether
ethyl enanthate
aether oenanthicus
ethyl heptylate
ethyl oenanthate
ethyl heptanoate, natural, >=98%, fg
ethyl heptanoate, >=98%, fcc, fg
ethyl heptanoate, reagentplus(r), 99%
BMSE000550
heptanoic acid ethyl ester
H0031
enanthic acid ethyl ester
A801415
NCGC00248014-01
cas-106-30-9
dtxcid9020112
dtxsid1040112 ,
tox21_300382
NCGC00254287-01
unii-45r404y5x8
45r404y5x8 ,
FT-0626189
AKOS015907945
ethyl oenanthate [mi]
ethyl heptanoate [fcc]
ethyl heptanoate [fhfi]
ethyl n-heptoate
SCHEMBL1585
hexane-6-carboxylic acid ethyl ester
ethyl ester of heptanoic acid
CHEMBL3184220
chebi:86618 ,
mfcd00009538
J-001569
LMFA07010984
ethyl heptanoate, purum, >=96.0% (gc)
ethyl heptanoate, analytical standard
ethyl heptanoate, vetec(tm) reagent grade, 98%
heptanoic acid-ethyl ester
ethyl heptoic acid
ethyl heptanoic acid
ethyl n-heptanoic acid
Q419765
E75824
ethyl2-(4-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxylate
ethyl heptanoate(heptanoic acid ethyl ester)
CS-W010893
HY-W010177
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
fatty acid ethyl esterA fatty acid ester that is the carboxylic ester obtained by the formal condensation of a fatty acid with ethanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoid X nuclear receptor alphaHomo sapiens (human)Potency12.29980.000817.505159.3239AID1159527
estrogen nuclear receptor alphaHomo sapiens (human)Potency43.45920.000229.305416,493.5996AID743075; AID743079
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency6.85900.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency43.27710.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's2 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.15 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]